SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Dave Mansfield who wrote (7851)6/9/1999 11:12:00 PM
From: American Spirit  Respond to of 9523
 
PFE should rebound tomorrow. Reaction overdone as usual.
The market always over-reacts. We're still on an upward journey here. Good news bad news in the drug sector. Let's hope for more good news next.



To: Dave Mansfield who wrote (7851)6/9/1999 11:45:00 PM
From: t2  Read Replies (1) | Respond to of 9523
 
Dave, I accept your explanation as valid. I guess my concern was that in the past, drug stock may have supported much lower PEs. With a high PE stock like PFE, I would think it would react to an increase in interest rates negatively just like the high PE technology companies. I guess your point would be that high interest rate environment in the domestic market would slow sales of the tech companies while drugs won't be affected. Is that logical?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News